Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.

Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.

Item
http://www.wikidata.org/entity/Q38152977
Regulatory T cells in multiple sclerosis and myasthenia gravis.Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetateAn MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.Smart branched polymer drug conjugates as nano-sized drug delivery systems.The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy.Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate.Liver injury and glatiramer acetate, an uncommon association: case report and literature review.Selected Issues on Regulation of the Circulation of Non-Biological Complex Drugs
P2860

Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.

Item
http://www.wikidata.org/entity/Q38152977
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Glatiramer acetate: a review o ...... y definite multiple sclerosis.
@en
type
label
Glatiramer acetate: a review o ...... y definite multiple sclerosis.
@en
prefLabel
Glatiramer acetate: a review o ...... y definite multiple sclerosis.
@en
P1433
P1476
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Glatiramer acetate: a review o ...... y definite multiple sclerosis.
@en
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921